Laura Leppan
Overview
Explore the profile of Laura Leppan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moss S, Stelfox M, McArthur E, Sriskandarajah C, Ahmed S, Birnie K, et al.
BMC Public Health
. 2024 Feb;
24(1):631.
PMID: 38413913
Background: Children and youth experienced marked impacts on day-to-day life in the COVID-19 pandemic that were associated with poorer familial and friend relationships, and greater mental health challenges. Few studies...
2.
Moss S, Racine N, Ahmed S, Birnie K, Cherak M, Curran J, et al.
BMJ Open
. 2023 Jun;
13(6):e072533.
PMID: 37369410
Introduction: On 11 March 2020, WHO declared the novel coronavirus (COVID-19) disease a global pandemic. Governments globally implemented physical distancing measures and closure of public institutions that resulted in varying...
3.
Parsons Leigh J, Moss S, Sriskandarajah C, McArthur E, Ahmed S, Birnie K, et al.
Sci Rep
. 2023 May;
13(1):7972.
PMID: 37198202
The COVID-19 pandemic negatively impacted the mental health of children, youth, and their families which must be addressed and prevented in future public health crises. Our objective was to measure...
4.
Halperin S, Ye L, MacKinnon-Cameron D, Smith B, Cahn P, Ruiz-Palacios G, et al.
Lancet
. 2021 Dec;
399(10321):237-248.
PMID: 34953526
Background: The Ad5-nCoV vaccine is a single-dose adenovirus type 5 (Ad5) vectored vaccine expressing the SARS-CoV-2 spike protein that was well-tolerated and immunogenic in phase 1 and 2 studies. In...